Literature DB >> 26116825

The ubiquitin ligase MuRF1 regulates PPARα activity in the heart by enhancing nuclear export via monoubiquitination.

Jessica E Rodríguez1, Jie-Ying Liao1, Jun He2, Jonathan C Schisler3, Christopher B Newgard4, Doreen Drujan5, David J Glass5, C Brandon Frederick6, Bryan C Yoder6, David S Lalush6, Cam Patterson7, Monte S Willis8.   

Abstract

The transcriptional regulation of peroxisome proliferator-activated receptor (PPAR) α by post-translational modification, such as ubiquitin, has not been described. We report here for the first time an ubiquitin ligase (muscle ring finger-1/MuRF1) that inhibits fatty acid oxidation by inhibiting PPARα, but not PPARβ/δ or PPARγ in cardiomyocytes in vitro. Similarly, MuRF1 Tg+ hearts showed significant decreases in nuclear PPARα activity and acyl-carnitine intermediates, while MuRF1-/- hearts exhibited increased PPARα activity and acyl-carnitine intermediates. MuRF1 directly interacts with PPARα, mono-ubiquitinates it, and targets it for nuclear export to inhibit fatty acid oxidation in a proteasome independent manner. We then identified a previously undescribed nuclear export sequence in PPARα, along with three specific lysines (292, 310, 388) required for MuRF1's targeting of nuclear export. These studies identify the role of ubiquitination in regulating cardiac PPARα, including the ubiquitin ligase that may be responsible for this critical regulation of cardiac metabolism in heart failure.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac metabolism; Cardiomyocyte; Fatty acid metabolism; Monoubiquitination; Muscle ring finger-1; Peroxisome proliferator-activated receptor α

Mesh:

Substances:

Year:  2015        PMID: 26116825      PMCID: PMC4523404          DOI: 10.1016/j.mce.2015.06.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  63 in total

1.  CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.

Authors:  S B Hake; K Masternak; C Kammerbauer; C Janzen; W Reith; V Steimle
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Stabilization of peroxisome proliferator-activated receptor alpha by the ligand.

Authors:  M Hirotani; T Tsukamoto; J Bourdeaux; H Sadano; T Osumi
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

Review 3.  Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth.

Authors:  John J Lehman; Daniel P Kelly
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

4.  Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

Authors:  P Escher; O Braissant; S Basu-Modak; L Michalik; W Wahli; B Desvergne
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

5.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

6.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

Authors:  P M Barger; J M Brandt; T C Leone; C J Weinheimer; D P Kelly
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 7.  PPAR signaling in the control of cardiac energy metabolism.

Authors:  P M Barger; D P Kelly
Journal:  Trends Cardiovasc Med       Date:  2000-08       Impact factor: 6.677

8.  Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.

Authors:  Kristine M Wadosky; Jessica E Rodríguez; Rebecca L Hite; Jin-na Min; Bethany L Walton; Monte S Willis
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

9.  Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes.

Authors:  Christophe Blanquart; Olivier Barbier; Jean-Charles Fruchart; Bart Staels; Corine Glineur
Journal:  J Biol Chem       Date:  2002-07-12       Impact factor: 5.157

10.  MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo.

Authors:  Taylor A Mattox; Martin E Young; Carrie E Rubel; Carolyn Spaniel; Jessica E Rodríguez; Trisha J Grevengoed; Mathias Gautel; Zhelong Xu; Ethan J Anderson; Monte S Willis
Journal:  J Bioenerg Biomembr       Date:  2014-04-15       Impact factor: 2.945

View more
  21 in total

1.  Lung injury-induced skeletal muscle wasting in aged mice is linked to alterations in long chain fatty acid metabolism.

Authors:  D Clark Files; Amro Ilaiwy; Traci L Parry; Kevin W Gibbs; Chun Liu; James R Bain; Osvaldo Delbono; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2016-07-26       Impact factor: 4.290

Review 2.  Thyroid hormone receptor localization in target tissues.

Authors:  Cyril S Anyetei-Anum; Vincent R Roggero; Lizabeth A Allison
Journal:  J Endocrinol       Date:  2018-02-12       Impact factor: 4.286

3.  MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.

Authors:  Kristine M Wadosky; Jessica M Berthiaume; Wei Tang; Makhosi Zungu; Michael A Portman; A Martin Gerdes; Monte S Willis
Journal:  J Mol Endocrinol       Date:  2016-02-09       Impact factor: 5.098

Review 4.  Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential.

Authors:  Traci L Parry; Monte S Willis
Journal:  Biochim Biophys Acta       Date:  2016-07-13

Review 5.  Proteasome biology and therapeutics in cardiac diseases.

Authors:  Sanket Kumar Shukla; Khadija Rafiq
Journal:  Transl Res       Date:  2018-09-28       Impact factor: 7.012

6.  Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.

Authors:  Roberto Mota; Jessica E Rodríguez; Andrea Bonetto; Thomas M O'Connell; Scott A Asher; Traci L Parry; Pamela Lockyer; Christopher R McCudden; Marion E Couch; Monte S Willis
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

7.  Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.

Authors:  Traci L Parry; Gopal Desai; Jonathan C Schisler; Luge Li; Megan T Quintana; Natalie Stanley; Pamela Lockyer; Cam Patterson; Monte S Willis
Journal:  Cardiovasc Pathol       Date:  2015-10-29       Impact factor: 2.185

Review 8.  PPARs: Protectors or Opponents of Myocardial Function?

Authors:  Christine J Pol; Melissa Lieu; Konstantinos Drosatos
Journal:  PPAR Res       Date:  2015-12-02       Impact factor: 4.964

9.  Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5.

Authors:  Yang Duan; Dawei Huo; Jie Gao; Heng Wu; Zheng Ye; Zhe Liu; Kai Zhang; Lin Shan; Xing Zhou; Yue Wang; Dongxue Su; Xiang Ding; Lei Shi; Yan Wang; Yongfeng Shang; Chenghao Xuan
Journal:  Nat Commun       Date:  2016-08-25       Impact factor: 14.919

10.  MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.

Authors:  Jun He; Megan T Quintana; Jenyth Sullivan; Traci L Parry; Trisha J Grevengoed; Jonathan C Schisler; Joseph A Hill; Cecelia C Yates; Rudo F Mapanga; M Faadiel Essop; William E Stansfield; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Yipin Han; Brian A Clarke; Monte S Willis
Journal:  Cardiovasc Diabetol       Date:  2015-08-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.